1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Twentyeight-Seven, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

Watertown MA US

Primary Industry

Biotechnology

About

Founded in 2016 and based in Massachusetts, US, Twentyeight-Seven, Inc. is a biotechnology company that develops therapeutics focusing on the modulation of non-coding RNA (ncRNA) function for the treatment of cancer and other human diseases.
Current Investors
Novartis Venture Fund, Astellas Venture Management, Johnson & Johnson Innovation

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biotechnology, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.twentyeight-seven.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo